Lung cancer screening guidelines inadequate for high-risk minorities

August 2, 2018, University of Illinois at Chicago
Lung CA seen on CXR. Credit: James Heilman, MD/Wikipedia

Data from a lung cancer screening program at the University of Illinois at Chicago provides evidence that national lung cancer screening guidelines, which were developed based on the National Lung Screening Trial, or NLST, in 2011 and recommend screening based on age and smoking history, may be insufficient for individuals in underrepresented communities.

The UIC researchers, who are members of the University of Illinois Cancer Center, found that when compared with patients in the NLST, the cohort of patients engaged in a Chicago-based lung program had a higher percentage of black (69.6 percent vs. 4.5 percent) and Latino (10.6 percent vs. 1.8 percent) individuals, double the number of positive scans (24.6 percent vs. 13.7 percent) and a higher percentage of diagnosed lung cancer cases (2.6 percent vs. 1.1 percent).

Their findings are published in JAMA Oncology.

The researchers say the data illustrates how the national trial is not representative of all people living in the U.S., particularly of minorities.

Senior author Dr. Lawrence Feldman says that comparing the national screening data to baseline screening data from a diverse and urban population, including patients who receive care at federally qualified health centers, provides insights that can help reduce the in lung cancer outcomes.

"Immunotherapies and other advances in medicine have come a long way in extending life and improving quality of life for many individuals diagnosed with lung cancer, but those advances mean much less for people living in underserved communities who can't access or are ineligible for screening programs," said Feldman, an oncologist at the University of Illinois Hospital and professor of clinical medicine in the UIC College of Medicine. "Screening that is offered based only on age and smoking history may miss a large group of people who are at higher risk due to other factors."

According to the American Lung Association, African-Americans not only get lung cancer at a higher rate than other groups, but they are also more likely to die from the disease. The ALA reports that African-American men, for example, are 22 percent more likely to die from lung cancer than white men.

Lead author Mary Pasquinelli, a UIC nurse practitioner, says that the guidelines for should be examined to see if additional risk factors, like a history of chronic obstructive pulmonary disease and having a close relative with cancer or a low education level, among other socioeconomic factors, should be considered alongside age and tobacco use when evaluating a person's eligibility for screening.

"We know screening is effective, but these data show us that we really need to start thinking about more expansive, risk-based screening guidelines, especially if we want to close the gap when it comes to racial disparities in outcomes," Pasquinelli said. "Otherwise, continued use of screening guidelines that are skewed toward the white population could actually increase racial disparities in outcomes."

The UIC study group consisted of 500 men and women who received care at the University of Illinois Hospital and Clinics or UI Health Mile Square Health Center, its network of federally qualified health centers. The mean age of participants was 62 years.

Explore further: Researchers identify the most accurate risk prediction models for selecting whom to screen for lung cancer

More information: JAMA Oncology (2018). DOI: 10.1001/jamaoncol.2018.2823 , https://jamanetwork.com/journals/jamaoncology/fullarticle/2694875

Related Stories

Researchers identify the most accurate risk prediction models for selecting whom to screen for lung cancer

May 15, 2018
Four risk prediction models have been shown to be most accurate for selecting the highest risk ever-smokers for lung cancer screening. Researchers suggest that this data can be used to inform future lung cancer screening ...

Prediction tool helps tailor lung cancer screening to patients

May 30, 2018
(HealthDay)‚ÄĒPersonalizing the harm-benefit assessment of low-dose computed tomography (LDCT) screening for lung cancer can inform patient-centered screening decisions, according to a study published online May 29 in the ...

Risk-based lung cancer screening may save more lives than current USPSTF guidelines

January 2, 2018
Lung cancer screening based on individual risk has the potential to save more lives than current recommendations by the U.S. Preventive Services Task Force (USPSTF). The findings are published in Annals of Internal Medicine.

Risk-based CT screening may reduce deaths from lung cancer

January 1, 2018
Compared to National Lung Screening Trial criteria, targeting screening those at highest risk from lung cancer mortality using a risk prediction tool may improve efficiency in terms of greater reduction in mortality from ...

Smokers who receive CT lung screening are more likely to quit

July 24, 2017
Smokers who undergo a CT scan of their lungs are more likely to quit than those who don't, concludes a trial led by Cardiff University.

Community engagement interventions may reduce disparities in lung cancer outcomes among minorities

October 18, 2017
Community-based interventions implemented in minority community sites resulted in changes in participants' knowledge, attitudes and beliefs about cancer, as well as perceived benefits and self-efficacy measures regarding ...

Recommended for you

Two ways cancer resists treatment are actually connected, with one activating the other

December 18, 2018
Drugs that target BRAF and MEK in cancer have shown promise in treating a subset of melanoma that carries a mutation in the BRAF gene, but drug resistance usually emerges, reversing the benefit of these drugs and limiting ...

HPV discovery raises hope for new cervical cancer treatments

December 18, 2018
Researchers at the University of Virginia School of Medicine have made a discovery about human papillomavirus (HPV) that could lead to new treatments for cervical cancer and other cancers caused by the virus.

Vaccine, checkpoint drugs combination shows promise for pancreatic cancers

December 18, 2018
Researchers at the Johns Hopkins Kimmel Cancer Center discovered a combination of a cancer vaccine with two checkpoint drugs reduced pancreatic cancer tumors in mice, demonstrating a possible pathway for treatment of people ...

Researchers identify ways breast cancer avoids immune system detection

December 18, 2018
Recent breakthroughs in immunotherapy are making a huge difference in treating some forms of cancer, especially metastatic cancer. But breast cancer has proven a tricky foe for this new therapy, and an interdisciplinary team ...

Metal chemotherapy drugs boost the impact of immunotherapy in cancer

December 18, 2018
Due to their powerful tumour-killing effect, metal-based chemotherapies are frequently used in cancer treatment. However, it was hitherto assumed that they damaged the immune system, because of their cytotoxic (cell-damaging) ...

10-year follow-up after negative colonoscopies linked to lower colorectal cancer risk

December 17, 2018
Ten years after a negative colonoscopy, Kaiser Permanente members had 46 percent lower risk of being diagnosed with and were 88 percent less likely to die from colorectal cancer compared with those who did not undergo colorectal ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Anonym518498
1 / 5 (1) Aug 02, 2018
stop smoking duh
barakn
not rated yet Aug 27, 2018
"Screening that is offered based only on age and smoking history may miss a large group of people who are at higher risk due to other factors." Poor reading comprehension, huh Anonym518498?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.